These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25128719)

  • 61. Immunological roles for resistin and related adipokines in obesity-associated tumors.
    Zhang J; Lu E; Deng L; Zhu Y; Lu X; Li X; Li F; Yan Y; Han JY; Li Y; Zhang Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):112911. PubMed ID: 39232363
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Physiological significance of resistin and resistin-like molecules in the inflammatory process and insulin resistance.
    Asano T; Sakosda H; Fujishiro M; Anai M; Kushiyama A; Horike N; Kamata H; Ogihara T; Kurihara H; Uchijima Y
    Curr Diabetes Rev; 2006 Nov; 2(4):449-54. PubMed ID: 18220647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.
    Spyrou N; Avgerinos KI; Mantzoros CS; Dalamaga M
    Curr Obes Rep; 2018 Dec; 7(4):260-275. PubMed ID: 30145771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The obesity-cancer link: lessons learned from a fatless mouse.
    Hursting SD; Nunez NP; Varticovski L; Vinson C
    Cancer Res; 2007 Mar; 67(6):2391-3. PubMed ID: 17363554
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adipokines: linking obesity and cardiovascular disease.
    Bell-Anderson KS
    Expert Rev Endocrinol Metab; 2008 Jan; 3(1):61-73. PubMed ID: 30743786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.
    Dalamaga M
    World J Exp Med; 2013 Aug; 3(3):34-42. PubMed ID: 24520544
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis.
    Devanoorkar A; Kathariya R; Guttiganur N; Gopalakrishnan D; Bagchi P
    Dis Markers; 2014; 2014():930206. PubMed ID: 24692844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adipose tissue as an endocrine organ.
    McGown C; Birerdinc A; Younossi ZM
    Clin Liver Dis; 2014 Feb; 18(1):41-58. PubMed ID: 24274864
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Resistin: functional roles and therapeutic considerations for cardiovascular disease.
    Jamaluddin MS; Weakley SM; Yao Q; Chen C
    Br J Pharmacol; 2012 Feb; 165(3):622-32. PubMed ID: 21545576
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis.
    Fülöp P; Harangi M; Seres I; Paragh G
    Chem Biol Interact; 2016 Nov; 259(Pt B):388-393. PubMed ID: 27062889
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Kouroumalis EA
    Inflamm Bowel Dis; 2005 Sep; 11(9):847-55. PubMed ID: 16116320
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is resistin the master link between inflammation and inflammation-related chronic diseases?
    Taouis M; Benomar Y
    Mol Cell Endocrinol; 2021 Aug; 533():111341. PubMed ID: 34082045
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein.
    Hoo RL; Yeung DC; Lam KS; Xu A
    Expert Rev Endocrinol Metab; 2008 Jan; 3(1):29-41. PubMed ID: 30743783
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adipocytokines: The pied pipers.
    Gandhi H; Upaganlawar A; Balaraman R
    J Pharmacol Pharmacother; 2010 Jan; 1(1):9-17. PubMed ID: 21808585
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Obesity associated hypertension: new insights into mechanism.
    Kang YS
    Electrolyte Blood Press; 2013 Dec; 11(2):46-52. PubMed ID: 24627704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Resistin: A reappraisal.
    Acquarone E; Monacelli F; Borghi R; Nencioni A; Odetti P
    Mech Ageing Dev; 2019 Mar; 178():46-63. PubMed ID: 30650338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Resistin: It's role in insulin resistance and mechanism of action].
    Ren Y; Zuo ZC; Wan TM
    Sheng Li Xue Bao; 2016 Feb; 68(1):65-74. PubMed ID: 26915324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of adipocytokines in atherogenesis and atheroprogression.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):295-320. PubMed ID: 25382206
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines.
    Emamalipour M; Seidi K; Jahanban-Esfahlan A; Jahanban-Esfahlan R
    J Cell Physiol; 2019 Dec; 234(12):21758-21769. PubMed ID: 31187484
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relation between resistin, PPAR-γ, obesity and atherosclerosis in male albino rats.
    Sabry MM; Dawood AF; Rashed LA; Sayed SM; Hassan S; Younes SF
    Arch Physiol Biochem; 2020 Dec; 126(5):389-398. PubMed ID: 30612469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.